Giorgia Renga

13PUBLICATIONS
54CO-AUTHORS
Molecular targetsFood properties (incl. characteristics and health benefits)Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 28, 2025
Glucocorticoids Downregulate PD-L1 in Glioblastoma Cells via GILZ-Mediated ERK Inhibition.

Sabrina Adorisio, Giorgia Renga, Domenico Vittorio Delfino

|May 08, 2024
The immune and microbial homeostasis determines the Candida-mast cells cross-talk in celiac disease.

Giorgia Renga, Marilena Pariano, Fiorella D'Onofrio

|Sep 28, 2022
CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models.

Michelle Seif, Tamara Katharina Kakoschke, Frank Ebel

|Mar 03, 2022
Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite.

Giorgia Renga, Emilia Nunzi, Marilena Pariano

|Aug 30, 2021
In vivo active organometallic-containing antimycotic agents.

Riccardo Rubbiani, Tobias Weil, Noemi Tocci

|Aug 27, 2021
A Shifted Composition of the Lung Microbiota Conditions the Antifungal Response of Immunodeficient Mice.

Emilia Nunzi, Giorgia Renga, Melissa Palmieri

Pageof 3